Eat Just’s chicken products get green light from Singapore agency
by CM Staff
The SFA's approval is aligned with Singapore's target to produce 30 per cent of its nutritional needs in-country by 2030, via the combination of cell-based agriculture.
VANCOUVER — Food Science Corp. an investment platform with a focus on lab-grown food has announced that its San Francisco, California-based portfolio company, Eat Just Inc., has received approval from the Singapore Food Agency to sell new types of cultivated chicken products, including chicken breast, beginning next year.
According to a company statement, the SFA’s approval is aligned with Singapore’s target to produce 30 per cent of its nutritional needs in-country by 2030, via the combination of cell-based agriculture. The company also stated that cell-based proteins have the potential to be more scalable than traditional meat products as large volumes of cell-cultured foods can be produced using less land and labour.
The Food Science Corp. also stated that Eat Just’s GOOD Meat division completed a US$97 million financing as part of a total US$267 million round.
According to the Food Science Corp., Eat Just formed the GOOD Meat division in 2017 when CULT’s Portfolio Company announced that it was developing a lab-grown meat product to make chicken nuggets. The company stated that GOOD Meat produces its products in a sterile environment from a single cell, thereby removing slaughter from the process and lowering the risk of food-borne illness. The company grows its cell-based meat in a bioreactor in fluid primarily containing amino acids, sugar, and salt.
Eat Just also announced plans for private tasting sessions of its chicken products to be hosted at the JW Marriott Hotel Singapore South Beach during the week of December 20, 2021.
“CULT applauds Eat Just’s receipt of additional approvals from the Singapore Food Agency as continued evidence of its industry leading production, compliance and innovation capabilities. A core holding of CULT’s investment portfolio, GOOD Meat’s progress further crystalizes CULT as the most accessible and democratized pure-play platform for cell-based foods and associated IP and research opportunities,” said Dorian Banks, CEO of CULT in a statement.
